Hemophilia: Types, Symptoms, Causes & Treatments

Most cuts and bruises stop bleeding within a few minutes. But people who are born with hemophilia or have acquired hemophilia may not be able to form proper blood clots; as a result, bleeding is longer than usual. Hemophilia is a lifelong condition, but recent advances in treatment have made it possible for many people to live healthy and active lives.

What Is Hemophilia? 

Hemophilia bleeding disorder is an inherited disease that prevents the blood from clotting properly, making it harder to stop bleeding. The main reason behind it is that the body lacks sufficient amounts of specific clotting proteins, known as clotting factors.

When a blood vessel is injured, the body initiates a complicated process. Your blood contains 13 clotting factors. Platelets gather at the site of the injury, and the proteins work in a sequence to form a clot. This clot helps in preventing excess blood loss from the body by acting as a natural barrier. But in people with hemophilia the factor is either missing or present in low levels. 

Why Does Hemophilia Cause Excessive Bleeding?

Blood clotting functions through a chain reaction, which involves multiple clotting factors. Even when one factor is missing, the entire process breaks down. A simple way to understand it is to think of blood clotting as a chain. Every clotting factor is a link that connects to the next. If one link is missing or weak, the chain breaks, and the body cannot form a stable blood clot.

How Common Is Hemophilia? 

Hemophilia bleeding disorder, is considered a rare disorder, but it affects many individuals around the world.

What is Acquired Hemophilia? 

This type does not have anything to do with genetics. Instead, this happens when the immune system mistakenly attacks the clotting factors. It can happen in older adults, during pregnancy, or alongside autoimmune conditions.

What are the Causes and Risk Factors? 

Most people with hemophilia are born with the condition, but in rare cases, it can develop later in life. Understanding the common causes and risk factors can help you better understand the condition.

1. Genetic Inheritance 

Hemophilia A and B are caused by genetic mutations in the genes found on the X chromosome. Males have only one X chromosome, and if there’s a single bad copy, this means they will have the condition. Females, on the other hand, carry two X chromosomes, so if one is affected, the other one compensates, making them immune (though not always). 

2. Spontaneous Genetic Mutations

It is not necessary that only people with a family history get diagnosed with Hemophilia. In some cases, a new genetic mutation occurs spontaneously during fetal development. As a result, the child may be born with the condition. 

3. Autoimmune Disorders 

Autoimmune disease can increase the risk of acquired hemophilia. In the case of autoimmune disease, the immune system mistakenly produces such antibodies that attack the clotting factors themselves, as a result of which blood clots do not form. There are conditions such as rheumatoid arthritis, lupus, and others that may lead to the development of hemophilia.

4. Pregnancy and the Postpartum Period 

It is rare, though some women develop acquired hemophilia during pregnancy or soon after giving birth to a child. The main reason is not clear, but due to changes in the immune system during and after pregnancy, it triggers the development of antibodies against clotting factors.

What are the Symptoms of Hemophilia? 

The symptoms vary depending on the type and severity of the condition, but there are some patterns that consistently show up. These include: 

• Unexplained or excessive bruising.
• Prolonged bleeding from cuts, dental work, or vaccinations.
• Nosebleeds happen frequently and are difficult to stop.
• Blood in urine or stool.
• Pain in joints, swelling or tightness.
• Headaches after minor head injuries.

How Is Hemophilia Diagnosed?

The first step of the diagnosis includes enquiries about the family history of bleeding problems and bruising issues. Since hemophilia often requires lifelong medical care, planning for treatment costs is equally important. NRI health insurance can help eligible NRIs secure healthcare coverage for their loved ones in India.

• Doctors may recommend a complete blood count (CBC) to examine overall blood health.
• A clotting test (PTT) to see how long blood takes to clot.
• Factor activity tests to identify which clotting factor is missing or low.
• Genetic testing to confirm the condition and identify the specific gene mutation. 

Genetic testing is becoming increasingly common, especially when hemophilia runs in the family. Besides confirming a diagnosis, it can help identify female carriers and support informed family planning decisions. Comprehensive plans from Niva Bupa can help cover eligible medical expenses, depending on the policy terms and conditions.

Treatment Options for Hemophilia 

The modern care for Hemophilia has evolved. Factor replacement used to be the only option. But now there are different approaches, each suitable for different patient profiles: 

Factor Replacement Therapy 

Factor replacement therapy is one of the most effective and widely used treatments for hemophilia. It works by replacing the missing or deficient clotting factor through an injection into a vein. This restores the blood's ability to clot properly, helping control bleeding and reducing the risk of complications. There are two main approaches:

• On-demand therapy: The clotting factor is administered after a bleeding episode begins to stop active bleeding.
• Prophylaxis: Regular infusions, typically 2–3 times a week, are given to prevent bleeding episodes before they occur.

Desmopressin (DDAVP)

DDAVP is mostly used to treat people with mild Hemophilia A. It encourages the body to release more of its own clotting factor, helping blood clot more effectively. While it doesn't work for Hemophilia B and isn't suitable for every patient, it can be a convenient option for managing minor bleeding episodes without needing regular factor infusions.

Antifibrinolytic Medications  

Drugs like tranexamic acid and aminocaproic acid work differently. Rather than replacing missing clotting factors, they prevent clots that do form from breaking down too quickly. They're often used as adjuncts, especially around dental procedures or for managing minor bleeding.

Non-Factor Replacement Therapies

Emicizumab (sold as Hemlibra) has changed the traditional treatment process for hemophilia, especially for Hemophilia A patients, including those who've developed inhibitors (antibodies that destroy infused Factor VIII, one of the toughest complications in hemophilia management).

It acts like Factor VIII, and as a result, inhibitors don’t recognise it.  It's given as a subcutaneous injection once weekly, every two weeks, or monthly, which is a massive improvement in convenience over IV infusions. 

Gene Therapy for Hemophilia

This area is getting the most attention in Hemophilia research. The procedure focuses on the root causes instead of managing symptoms. It operates by delivering a working copy of the affected gene directly into liver cells. The liver then produces the missing clotting factor on its own.

How Can People with Hemophilia Lead an Active Life?

With the right treatment and proper care, it is possible to live a healthy and active life:

• Exercise:  You can participate in low-impact activities like swimming, cycling, and walking. Even though contact sports carry a higher risk, you don’t necessarily need to avoid them completely. It depends on severity and treatment.
• Dental care: Good oral hygiene reduces the risk of procedures, but when dental work is needed, the treating team needs to know in advance so clotting factor cover can be arranged.
• Travel:  When you are travelling, it becomes really important to carry a medical alert card, pack sufficient factor concentration, and know which hospitals in your destination treat bleeding disorders. 
• School and work: Most people with hemophilia don't need major accommodations, but having an emergency plan in place (particularly for children) is a good precaution.

Conclusion

Hemophilia is a lifelong bleeding disorder, but it doesn’t have to limit your quality of life. Treatment options have evolved a lot, from factor replacement therapy and newer non-factor treatments to promising advances in gene therapy. People living with hemophilia now have more choices than ever before. With early diagnosis, the right treatment plan, and regular medical care, most people with hemophilia can effectively manage their condition and go about their daily lives. Along with timely medical care, having comprehensive health insurance, NRI health insurance, from Niva Bupa can help manage the financial burden of eligible treatments and hospitalisation, so you can focus on living life with greater confidence.

Frequently Asked Questions (FAQs)

1.  Is hemophilia bleeding disorder curable?

Not in the traditional sense — but gene therapy is the closest thing to a functional cure currently available. For eligible patients, a single treatment has produced sustained factor production for years in clinical trials. Whether that translates to a lifetime benefit is still being studied.

2. What's the difference between Hemophilia A and B?

Hemophilia A involves a Factor VIII deficiency; Hemophilia B involves Factor IX. They present similarly but require different replacement therapies. Hemophilia B is less common and was historically harder to treat, though gene therapy options now exist for both.

3. Can females have hemophilia bleeding disorder?

Yes. It's uncommon, but female carriers can experience significant bleeding symptoms, and women with mutations on both X chromosomes will have the condition outright.

4. What is the life expectancy of a person with hemophilia?

With comprehensive care, life expectancy is now close to that of people without hemophilia. Around the 1980s, the gap used to be significant; many didn't survive to middle age, partly due to HIV transmission through contaminated blood products. Modern recombinant therapies carry none of that risk.